GSK continues shift in strategic direction
The pace of change at GlaxoSmithKline (GSK) is showing no sign of slowing, with new CEO Andrew Witty unveiling the company’s new strategic direction with the release of second quarter results.
Archives for July 23, 2008
West African conference to eradicate counterfeits
West African states are meeting to devise a plan for cleaning up their tarnished reputations with regards to the flow of counterfeit pharmaceuticals in the region.
Proboscis-mimicking microneedle for drug delivery
Researchers from India and Japan claim to have developed a compact medical device capable of painlessly monitoring a patients insulin levels and administering the required dose.
ESA's CAD improves detection of API impurities
UK-headquartered ESA Biosciences has unveiled a new system for the identification of low levels organic impurities during the production of active pharmaceutical ingredients (API).
Lab suppliers post solid Q2 growth despite the credit crisis
With fears of a global recession riding on the back of the credit crisis, many laboratory suppliers have managed to weather the storm and still achieve double digit sales growth in the second quarter of 2008.
FDA relaxes GMP rules for Ph I candidates
The US Food and Drug Administration (FDA) has relaxed the regulatory good manufacturing practice (GMP) rules for drugs in early-stage clinical trials in recognition of the different requirements of trial scale and industrial scale manufacture.
Small molecules drive Lonza contract unit in 1H
Lonza of Switzerland is reaping the benefit of a shift away from bulk chemicals and towards custom manufacturing of high-value pharmaceuticals with a 13 per cent hike in sales in the first half of the year.
Medtox sees dip in clinical lab services, but profits rise
Laboratory services and diagnostics company Medtox Scientific has posted a healthy hike in operating profits for the second quarter, despite a challenging operating environment that pegged back sales growth.